medigraphic.com
ISSN 1028-4818 (Electronic)

2015, Number 2

<< Back Next >>

Mul Med 2015; 19 (2)

Risk factors in patients with Kidney Cancer

Sánchez IML, Martínez LRS, Rivero MJC, Romero CY, Vega VR

Language: Spanish
References: 14
Page:
PDF size: 178.98 Kb.


ABSTRACT

Introduction: renal adenocarcinoma described by Koing and known as Grawitz tumor represents approximately 3% of all malignant neoplasias in human beings and the female–male ratio of 2.1 is more frequent in the urban area and the most affected patients are between 50 and 70 years internationally.
Objective: to identify the influence of certain risk factors in the onset of the disease.
Method: it was performed a retro descriptive and prospective study where it was analyzed the surgical treatment of kidney cancer in the University Province Hospital "Carlos Manuel de Céspedes", since January 2008 to January 2013, distributing the patients according to age and sex, symptoms, treatment, metastasis and survival time.
Results: it was found that the cancer was more frequent in women between 50 and 59 years. The prevailing symptoms were lumbar pain and hematuria. The most frequent metastases were in the liver and in soft parts. The deceased were 4 patients: 3 women and a man.
Conclusions: the mostly used therapeutic procedure was the radical nephrectomy; the urinary infection prevailed as a complication. The clear cell carcinoma was the histological type that prevailed. Survival was greater in males. The right renal tumor prevailed on the left tumor.


REFERENCES

  1. Chisholm GD, Roy RR. The systemic eftects oy malignat renal tumors. Br J Urol [Internet]. 1971 [citado 23 de marzo de 2015]; 43: 687 – 700. Disponible en: http://onlinelibrary.wiley.com/doi/10.1111/j.1464-410X.1971.tb12089.x/pdf

  2. Glenn JF. Specnlation on Genesis, Therapeusis and Proggnosis of Nephrocarcinoma. En. Glenn JF. Renal Neoplasia. Boston : [s/n]; 2009.p. 535-46.

  3. Gilberti C, Oneto F, martorana G, Rovida S, carmignani G. Radical nephrectomy for renal cell carcinoma. Long – term results and prognostic factors on a series of 328 cases. Eur Urol [Internet]. 1997 [citado 23 de marzo de 2015]; 31(1):40-1. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/9032533

  4. Whitmure WF, Krause C: Survival Following Nephrectomy for Renal Cell Cancer. En. King JS. Renal Neoplasia. Boston :[s/n]; 2008.p.447-59.

  5. Mimns NM, Christianson B. A ten year cualuation of nephrectomy for extensive renal cell carcinoma. J Urol 2008; 95:10.

  6. Sanz-Ortega J, Olivier C, Pérez Segura P, Galante Romo I, San José Mansó L. Cáncer de riñón hereditario. Actas Urol Esp [Internet]. 2009 Feb [citado 2015 Mar 23]; 33(2): 127-133. Disponible en:. http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0210-48062009000200005&lng=es&nrm=iso&tlng=es

  7. Moskvina LV, Andreva L, Malkov PG. Pronostic factors renal cell carcinoma. Arkh Patol [Internet]. 2011 [citado 23 de marzo de 2015]; 73(6):47-52. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/22379902

  8. Auperin A, Benhemov S, Ory-Paoletti C, Flamant R. Occupational risk factors for renal cell carcinoma: a case control study. Ocupatinal Enviromental Medicine [Internet]. 1994 [citado 23 de marzo de 2015]; 51: 426 -8. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1128000/pdf/oenvmed00054-0066.pdf

  9. Baltaci S, Diciehan O, Sedal S, Yasan B, Tulunay O, Orhan G, et al. Influence of tumor stage size, vascular involvement, histological cell type and histological pattern on multifocality of renal cell carcinoma. J Urology [Internet]. 2001 [citado 23 de marzo de 2015]; 164(1): 36-9. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/10840419

  10. Medina López R, Congregado Ruiz E, Campo Martínez P, Morales López A, Sánchez Gómez E, Pobil Moreno L, et al. Cáncer renal: análisis descriptivo de una serie de 267 casos intervenidos. Arch Esp Urol [Internet]. 2001[citado 23 de marzo de 2015]; 54(1): 423-8. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/?term=C%C3%A1ncer+renal%3A+an%C3%A1lisis+descriptivo+de+una+serie+de+267+casos+intervenidos

  11. Díaz Placencia J, Sánchez Ferren L, Rodríguez Espep R, Colipuy Abanto W, Rojas Martínez F. Adenocarcinoma renal: cuadro clínico y sobrevida. Oncología 2010; 9:289.

  12. Mc Laughlin J, Gad Y, Gao R, Zheng W, Blot W. Ris factors for renal- cell caner in Shanghai, China. Int J Cancer [Internet]. 1992 [citado 23 de marzo de 2015]; 52(4):562-5. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/1399137

  13. Pérez Arbel J, Espuela Orgaz R, Vegueras Gimeno M, Márquez E, Arnaiz Esteban F, Crespo Mayor U, et al. Historia natural del cáncer de riñón, seguimiento iconográfico. Arch Esp de Urol 1998 51(8):745-9.

  14. Thrasher JB, Paulson DF. Prognostic factors in renal cancer. Urol Clin North Am [Internet]. 1993 [citado 23 de marzo de 2015]; 20(2):247-62. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/8493748




2020     |     www.medigraphic.com